Status:
COMPLETED
Problems With Immune Recovery in the Gut Tissue
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Human Immunodeficiency Virus
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to find out if the process of HIV replication in the lymph tissue and gut tissue of people taking HIV drugs causes long-term damage to the ability of the gut to protect you fr...
Eligibility Criteria
Inclusion
- HIV+ individuals
- Seropositive for HIV
- On ART for at least 12 months
- Seropositive for Herpes Simplex Type 2 and Cytomegalovirus
- Age ≥ 18 years
- Negative pregnancy test for eligible women of childbearing potential
- HIV- individuals
- Seronegative for HIV
- Seropositive for Herpes Simplex Type 2 and Cytomegalovirus
- Age ≥ 18 years
- Negative pregnancy test for eligible women of childbearing potential
Exclusion
- Taking daily suppressive therapy for Herpes Simplex Type 2
- Contraindication to surgical \& endoscopic procedures (as judged by PI)
- Psychiatric or psychological illness that would make adherence to protocol procedures unlikely
- Pregnancy
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01460433
Start Date
September 1 2008
End Date
January 1 2013
Last Update
September 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455